Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a synthetic version of a hormone called thyroxine and, according to a recent report from the Radiological Society of North America (RSNA),

A widely used pill for treating an underactive thyroid may be associated with bone loss, according to a study being presented next week at the annual meeting of the Radiological Society of North America in Chicago.

New research indicates a link between levothyroxine and bone mass loss in older adults. Scientists emphasize the need to monitor its use in individuals at risk of negative effects. Levothyroxine, a popular medication used in the treatment of hypothyroidism,